Bellicum Pharmaceuticals

Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), is a specialty pharmaceutical company developing novel formulations of proven CNS agents to provide meaningful new patient benefits. Acquired by Paratek Pharmaceuticals in 2014.

Select Venture Capital & Financial Partners

BioAsia Investments Hamilton Apex Ventures, LP InterWest Partners Montreux Equity Partners New Enterprise Associates New Leaf Venture Partners